Trials / Completed
CompletedNCT00750984
A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- 29 Years – 61 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the posterior approach to the anterolateral approach using the ReCap® Total Hip Resurfacing System.
Detailed description
Theoretical considerations of RECAP procedures through anterolateral trochanteric osteotomy: * Less bone resection, less complicated revision surgery. * Reduced stress shielding of the femur. * Lower incidence of hip dislocations. * Walking function improved by change in mobilisation regime and operative technique. * Risk of femoral neck fracture is reduced by preoperative measurement of bone density. * Risk of avascular necrosis of the femoral head is reduced with the anterolateral approach preserving femoral head blood supply and preventing later failure of the implant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Anterolateral approach | The anterolateral approach is performed with the patient positioned on the side. The blood supply to the femoral neck from the medial circumflex artery is regarded preserved by this surgical method. |
| PROCEDURE | Posterior approach | The posterior approach is performed with the patient positioned on the side. The medial circumflex artery is cut at the lower border of the short external rotators risking a compromised blood supply to the femoral head. |
| DEVICE | ReCap Total Hip Resurfacing | This arm utilizes the anterolateral approach using the ReCap® Total Hip Resurfacing System. |
| DEVICE | ReCap Total Hip Resurfacing | This arm utilizes the posterior approach using the ReCap® Total Hip Resurfacing System. |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2013-07-01
- Completion
- 2017-02-01
- First posted
- 2008-09-11
- Last updated
- 2018-01-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00750984. Inclusion in this directory is not an endorsement.